Acute Porphyria Drugs

V03AF01 - Mesna

Probably not porphyrinogenic
PNP

Mono.Rationale
Non-hepatic, probably non-CYP metabolism.
Mono.ChemicalDescription
Sodium mercaptethane sulfonate administered during treatment with iophosphamide in order to counteract urinary tract toxicity caused by acroleine formed. Converted to free thiol in serum and eliminated in urine.
Mono.SimilarDrugs
Mono.ExploreAlternatives V03A / V03AF or Mono.GoBack.
Mono.References
Mono.Tradenames

Uromitexan Uromitexan Mesna · Uromitexan Mesna · Uromitexan Mesna · Uromitexan Uromitexan Uromitexan Uromitexan Mesna · Uromitexan Uromitexan Mesna · Mesna-Na-K · Uromitexan Uromitexan Uromitexan Mesna · Uromitexan Uromitexan Mesna · Uromitexan Mesna · Uromitexan Uromitexan Uromitexan Uromitexan Uromitexan Uromitexan Uromitexan Uromitexan Uromitexan Mesna · Mesna-Cell · Uromitexan Uromitexan
In cooperation with Ipnet
© Napos 2026
An unhandled error has occurred. Reload 🗙